Memantine in Moderate to Severe Alzheimer’s Disease: a Meta-Analysis of Randomised Clinical Trials

Publisher： Karger

E-ISSN： 1421-9824|24|1|20-27

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.24, Iss.1, 2007-05, pp. : 20-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of the Effect of Memantine in Reducing the Worsening of Clinical Symptoms in Patients with Moderate to Severe Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 2, 2007-07 ,pp. : 138-145

Karger

Access to resources Recommend Favorite

Cerebrolysin in Mild-to-Moderate Alzheimer's Disease: A Meta-Analysis of Randomized Controlled Clinical Trials

By  

Dementia and Geriatric Cognitive Disorders, Vol. 39, Iss. 5-6, 2015-03 ,pp. : 332-347

Karger

Access to resources Recommend Favorite

Systematic Review and Meta-Analysis of Combination Therapy with Cholinesterase Inhibitors and Memantine in Alzheimer’s Disease and Other Dementias

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 2, Iss. 1, 2012-11 ,pp. : 546-572

Karger

Access to resources Recommend Favorite

Specific Functional Effects of Memantine Treatment in Patients with Moderate to Severe Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 18, Iss. 2, 2004-08 ,pp. : 227-232

Karger

Access to resources Recommend Favorite

Memantine Therapy of Behavioral Symptoms in Community-Dwelling Patients with Moderate to Severe Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 2, 2009-02 ,pp. : 164-172

Karger

Access to resources Recommend Favorite